Skip to content
EntityQ600951· pop 14· linked from 84 articles

Also known as BE-1293, Diurexan®, MJF-10938

Xipamide () is a sulfonamide diuretic drug marketed by Eli Lilly under the trade names Aquaphor (in Germany) and Aquaphoril (in Austria). It is used for the treatment of oedema and hypertension.

~4 min read

Encyclopedic overview

12 sections
Contents
  • Mechanism of action
  • Uses
  • Pharmacokinetics
  • Dosage
  • Adverse effects
  • Contraindications
  • Interactions
  • Not recommended combinations
  • Combinations requiring special precautions
  • Interactions not included in the product information
  • Banned use in sport
  • References

Xipamide () is a sulfonamide diuretic drug marketed by Eli Lilly under the trade names Aquaphor (in Germany) and Aquaphoril (in Austria). It is used for the treatment of oedema and hypertension.

== Mechanism of action == Like the structurally related thiazide diuretics, xipamide acts on the kidneys to reduce sodium reabsorption in the distal convoluted tubule. This increases the osmolarity in the lumen, causing less water to be reabsorbed by the collecting ducts. This leads to increased urinary output. Unlike the thiazides, xipamide reaches its target from the peritubular side (blood side).

Excerpted from Wikipedia’s “xipamide” article, available under the CC BY-SA 4.0 licence.